Study of PX-866 and Vemurafenib in Patients With Advanced Melanoma
This study is currently recruiting participants.
Verified January 2013 by Oncothyreon Inc.
Sponsor:
Oncothyreon Inc.
Information provided by (Responsible Party):
Oncothyreon Inc.
ClinicalTrials.gov Identifier:
NCT01616199
First received: June 6, 2012
Last updated: January 8, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | March 2015 |
| Estimated Primary Completion Date: | December 2014 (Final data collection date for primary outcome measure) |